Company / Current Assets per Share
Denali Therapeutics Inc. Current Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$6.24
FY2025
5-year range
$6.24 / $11.22
FY2021-FY2025
Trend
-0.0%
vs FY2024
Sector context
#117 of 210
Health Care
What the data says
At $6.24, Denali Therapeutics Inc.'s current assets per share ranks #117 of 210 in the Health Care sector. Current Assets per Share has declined for 3 consecutive years, from $11.22 in FY2022 to $6.24 in FY2025.
Based on SEC 10-K filings.
6.24 in FY2025 with a 5-year CAGR of -16.7%.
Declined from $7.83 to $6.24 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -17.7%
- 5-Year CAGR
- -16.7%
- 10-Year CAGR
- -
Sector benchmark
#117 of 210 in Health CareTop 56% of 210This company $6.24 Sector average $134.38
▼
-95.4% below sector average
Key checks
Key Insights
- Denali Therapeutics Inc.'s current assets per share has declined for 3 consecutive years.
- In FY2025, current assets per share decreased 0.0% year-over-year.
- Ranks #117 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.73 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.24 | -0.0% |
| FY2024 | $6.25 | -20.2% |
| FY2023 | $7.83 | -30.3% |
| FY2022 | $11.22 | +50.8% |
| FY2021 | $7.44 | -52.1% |
| FY2020 | $15.55 | +242.3% |
| FY2019 | $4.54 | -17.4% |
| FY2018 | $5.50 | -79.9% |
| FY2017 | $27.37 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026